hrs4r
 I want to donate
“Innovation is seeing what everybody has seen and thinking what nobody has thought.”
Dr. Albert Szent- Györgyi (Premi Nobel de Medicina 1937)  
At the IDIBGI we promote innovative culture and encourage science and our research to generate knowledge that eventually applies to health care practice to improve the health of society and our environment.
The Innovation Department is responsible for the identification and valorization of research results, managing IDIBGI's Technology Transfer to society, collaborations with companies and organizations, offering training to research staff, management of Industrial and Intellectual property titles, support in calls for grants for innovation projects and advice for the creation of Technology-Based Companies.

At IDIBGI, we support the entire process of innovation in health and technology transfer of our research staff. The process includes the following phases:

  • Results detection phase: Identifying the innovative results obtained in research.
  • Results valorization phase: Analyze and evaluate the technologies detected to determine the possibility of their protection from the point of view of novelty and market potential.
  • Protection phase: Protection of research results before they are disclosed.
  • Validation phase: Defining, specifying and executing those proofs of concept prior to commercialization that allow obtaining a final product.
  • Commercialization phase: Plan and execute the necessary actions to identify and contact companies interested in commercializing the technology. Negotiation and management of the licensing contract. Possibility of creating spin-offs.

Services

IDIBGI's Innovation Department offers support services and tailor-made accompaniment to the research staff in the innovation process:

  • Advice
  • Valorization of results
  • Intellectual and industrial property
  • Entrepreneurship
  • Networking
  • Training
  • Technology promotion
  • Acceleration
  • We work in close collaboration with IDIBGI's Projects Department for the search and management of funding calls and the evaluation of the impact on project proposals.

Contact here with the Innovation department

Innovation Strategy and Management

Consolidate and professionalize the innovation unit, with the aim of adapting and developing the structure of the unit, improving the acquisition and management of innovation projects, and continuously training managers, support teams and researchers .
Enhance innovation in health, to stimulate innovative talent and support the planning and drafting of innovation projects.
Encourage technological and knowledge transfer, with the aim of supporting the valuation of ideas and the transferral of research results.
Enhance relationships with all innovation actors, in order to create a network of contacts and promote synergies between local and international innovation agents.
Activities
Innovation projects
Networks participation
Policies

Activities

The unit has carried out a series of activities related to innovation since its creation, among others, support in the creation of clinical guides, the organization of innovation conferences, collaborations with companies for strategic projects such as the Imagenoma of Aging and projects for the Mental Health Network (Fujitsu Labs, Toshiba Medical Systems / Canon) or the management of the pandemic originated by COVID-19 (HIPRA - collaboration for the development of an ELISA kit for the detection of COVID-19), as well as managing the intellectual property portfolio (9 patent families and 2 utility models), and supporting the creation of two spin-off companies (Goodgut and MetaboStem).


Innovation projects

The Innovation and transference Unit offers a personalized service to research personnel in relation to innovative ideas and inventions originating in the IDIBGI, with a process of internal and external support and advice in conjunction with sector experts (consulting, intellectual property agents, legal advice).

With the support of other BDU personnel we also offer advice on the impact of research results, an aspect of particular importance in developing competitive proposals.

 

Are you an investigator at the IDIBGI or an associated institution and have an innovative project?

Do you want to collaborate with other institutions or companies?

Contact us at innovacio@idibgi.org

If you have an invention or innovative project and want advice or want to request intellectual property protection contact us and download the Innovation File. 

Innovation file

Participation in networks

IDIBGI is part of the XarSmart network that promotes innovation in personalized precision medicine, medical devices and data science. Specifically, the group participates in the Neurodegeneration and Neuroinflammation research group.

The network brings together 30 research groups belonging to 13 research institutions in Catalonia, personalized precision medicine, medical devices and data science. XarSmart is promoted by the Bellvitge Biomedical Research Institute (IDIBELL) and funded by the Agency for the Management of University and Research Grants (AGAUR).

The members of the Innovation team are members of the Association of Research Transfer, Innovation and Management Professionals (RED TRANSFER).

i4KIDS Hub d’Innovació Pediàtrica (HIP) consists of more than 30 institutions of the R+D+I ecosystem of Catalonia and counts with the participation of 3 research groups from IDIBGI:

The IDIBGI is part of the Xarxa d'Innovació de Noves Tecnologies en Salut Mental (TECSAM Network) which promotes innovation in mental health. Specifically, the Mental Health and Addictions research group participates in this network.

Knowledge transfer

Technology offer
Clinical Guidelines
Spin-offs
Genetic Diagnostic Laboratory
Clinical research
Collaborations

Technology offer

PATENTS

José Manuel Fernández-Real, Jordi Mayneris, Josep Maria Del Bas Prior, Xavier Escoté Miró, Sergio Quesada Vázquez
Pharmaceutical and nutraceutical compositions with a combination of amino acids and its use in diseases characterized by lipid accumulation in tissues
Application Number: EP22382390

Technology offer

José Manuel Fernández-Real, Jordi Mayneris, Anna Castells Nobau, María Arnorriaga, Rafael Maldonado López, Andrés Moya, Vicente Pérez-Brocal
Bacteriófago para uso terapéutico
Application Number: P202130786

Technology offer

Jaume Marrugat De La Iglesia, Roberto Llanos Elosua, Anna Camps Vilaró, Isaac Subirana Cachinero, Xavier Nogues Solan, Joan Ramon Masclans, Roberto Güerro Fernández, Judith Marin Corral, Helena Tizon Marco, Ramón Brugada i Terradelles, Mel·lina Pérez Serra, Alexandra Pérez Serra, Rafel Ramos Blanes, Ruth Martí Lluch, Irene Roman Degano
Genetic markers for severe COVID-19
Application Number: EP22382342

Technology offer

Óscar Juan Pozo Mendoza , Àlex Gómez Gómez, Gabriel Gil Gómez, Manuel Roman Pera Roman, Laura Visa Turmo, Edurne Arriola Aperribay, Rosa Peracaula Miró, Esther Llop Escorihuela, Ernest Castro Gutiérrez, Adelaida García Velasco, Esther Fort Martorell, Dúnia Pérez Del Campo
Method for diagnosing cancer
Application Number: EP22382244

Technology offer

Lluís Ramió-Torrentà, Jordi Gich, Jordi Freixenet, Clàudia Coll, Judit Salavedra
EM-Line! Kids. Free online cognitive rehabilitation for Kids

Technology offer

Jaime Aboal (IDIBGI), Rafel Ramos (IDIAP Jordi Gol)
App ODISEA

Technology offer

SOFTWARE

EM-Line!

"Project EM-line!" is a cognitive rehabilitation program for neurological patients. It was designed so that the patient can use it free of charge from home, without interfering with their personal or professional activities.

https://www.em-line.com/

Lluís Ramió-Torrentà, Jordi Gich, Jordi Freixenet, Clàudia Coll, Judit Salavedra

 

ODISEA

ODISEA is a software that improves the coordination and flow of information between healthcare professionals attending an acute myocardial infarction.

https://www.odiseacodigoinfartoapp.es/

 

TDApp

TDApp is an application designed to facilitate the participation of patients and their families in making decisions about the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

https://tdapp.org/en/

 

Are you interested in our technological offer? Contact us

Clinical Guidelines

Granell Gil M,Murcia Anaya M,Sevilla S,Martínez Plumed R,Biosca Pérez E,Cózar Bernal F,Garutti I,Gallart L,Ubierna Ferreras B,Sukia Zilbeti I,Gálvez Muñoz C,Delgado Roel M,Mínguez L,Bermejo S,Valencia O,Real M,Unzueta C,Ferrando C,Sánchez F,González S,Ruiz Villén C,Lluch A,Hernández A,Hernández Beslmeisl J,Vives M,Vicente R. Clinical guide to perioperative management for videothoracoscopy lung resection (Section of Cardiac, Vascular and Thoracic Anesthesia, SEDAR; Spanish Society of Thoracic Surgery, SECT; Spanish Society of Physiotherapy). Rev Esp Anestesiol Reanim (Engl Ed). 2022. 69. (5):p. 266-301.

Palacio Portilla EJ,Roquer J,Amaro S,Arenillas JF,Ayo Martín O,Castellanos M,Freijo MM,Fuentes B,García Pastor A,Gomis M,Gómez Choco M,López Cancio E,Martínez Sánchez P,Morales A,Rodríguez Yáñez M,Segura T,Serena J,Vivancos Mora J,de Leciñana MA,Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la S. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurologia. 2022. 37. (1):p. 61-72. IF:5,486. (Q1).

García Pastor A,López Cancio Martínez E,Rodríguez Yáñez M,Alonso de Leciñana M,Amaro S,Arenillas JF,Ayo Martín O,Castellanos M,Fuentes B,Freijo MM,Gomis M,Gómez Choco M,Martínez Sánchez P,Morales A,Palacio Portilla EJ,Segura T,Serena J,Vivancos Mora J,Roquer J,Ad hoc committee of the Spanish Society of Neurology's Cerebrovascular Disease S. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution. Neurologia (Engl Ed). 2021. 36. (5):p. 377-387.

Fuentes B,Amaro S,Alonso de Leciñana M,Arenillas JF,Ayo Martín O,Castellanos M,Freijo M,García Pastor A,Gomis M,Gómez Choco M,López Cancio E,Martínez Sánchez P,Morales A,Palacio Portilla EJ,Rodríguez Yáñez M,Roquer J,Segura T,Serena J,Vivancos Mora J,Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la S. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Neurologia. 2021. 36. (4):p. 305-323. IF:5,486. (Q1).

Nadal E,Bosch Barrera J,Cedrés S,Coves J,García Campelo R,Guirado M,López Castro R,Ortega AL,Vicente D,de Castro Carpeño J. SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020). Clin Transl Oncol. 2021. 23. (5):p. 980-987. IF:3,340. (Q3).

Redondo A,Guerra E,Manso L,Martin Lorente C,Martinez Garcia J,Perez Fidalgo JA,Varela MQ,Rubio MJ,BARRETINA P,Gonzalez Martin A. SEOM clinical guideline in ovarian cancer (2020). Clin Transl Oncol. 2021. 23. (5):p. 961-968. IF:3,340. (Q3).

Luque R,Benavides M,Del Barco S,Egaña L,García Gómez J,Martínez García M,Pérez Segura P,Pineda E,Sepúlveda JM,Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021. 23. (5):p. 940-947. IF:3,340. (Q3).

Pajares MA,Margarit JA,García Camacho C,García Suarez J,Mateo E,Castaño M,López Forte C,López Menéndez J,Gómez M,Soto MJ,Veiras S,Martín E,Castaño B,López Palanca S,Gabaldón T,Acosta J,Fernández Cruz J,Fernández López AR,García M,Hernández Acuña C,Moreno J,Osseyran F,Vives M,Pradas C,Aguilar EM,Bel Mínguez AM,Bustamante Munguira J,Gutiérrez E,Llorens R,Galán J,Blanco J,Vicente R. Guidelines for enhanced recovery after cardiac surgery. Consensus document of Spanish Societies of Anesthesia (SEDAR), Cardiovascular Surgery (SECCE) and Perfusionists (AEP). Rev Esp Anestesiol Reanim (Engl Ed). 2021. 68. (4):p. 183-231.

Palacio Portilla EJ,Roquer J,Amaro S,Arenillas JF,Ayo Martín O,Castellanos M,Freijo MM,Fuentes B,García Pastor A,Gomis M,Gómez Choco M,López Cancio E,Martínez Sánchez P,Morales A,Rodríguez Yáñez M,Segura T,Serena J,Vivancos Mora J,de Leciñana MA,Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la S. Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology. Neurologia (Engl Ed). 2020. 37. (1):p. 61-72.

Avilés Jurado FX,Álvarez Escudero J,Aldecoa Álvarez Santuyano C,de Haro López C,Díaz de Cerio Canduela P,Ferrandis Perepérez E,Ferrando Ortolá C,Ferrer Roca R,Hernández Tejedor A,López Álvarez F,Monedero Rodríguez P,Ortiz Suñer A,Parente Arias P,Planas Roca A,Plaza Mayor G,Rascado Sedes P,Sistiaga Suárez JA,Vera Ching C,Villalonga Vadell R,Martín Delgado MC,Bernal Sprekelsen M. Consensus Document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on Tracheotomy in Patients with COVID-19 Infection. Rev. Esp. Anestesiol. Reanim. 2020. 67. (9):p. 504-510.

Bernal Sprekelsen M,Avilés Jurado FX,Álvarez Escudero J,Aldecoa Álvarez Santuyano C,de Haro López C,Díaz de Cerio Canduela P,Ferrandis Perepérez E,Ferrando Ortolá C,Ferrer Roca R,Hernández Tejedor A,López Álvarez F,Monedero Rodríguez P,Ortiz Suñer A,Parente Arias P,Planas Roca A,Plaza Mayor G,Rascado Sedes P,Sistiaga Suárez JA,Vera Ching C,Villalonga Vadell R,Martín Delgado MC. Documento de consenso de la Sociedad Española de Medicina Intensiva, Crítica, y Unidades Coronarias (SEMICYUC), la Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello (SEORL-CCC) y la Sociedad Española de Anestesiología y Reanimación (SEDAR) sobre la traqueotomía en pacientes con COVID-19. Acta Otorrinolaringol Esp (Engl Ed). 2020. 71. (6):p. 386-392.

Ballesteros Sanz MÁ,Hernández Tejedor A,Estella Á,Jiménez Rivera JJ,González de Molina Ortiz FJ,Sandiumenge Camps A,Vidal Cortés P,de Haro C,Aguilar Alonso E,Bordejé Laguna L,García Sáez I,Bodí M,García Sánchez M,Párraga Ramírez MJ,Alcaraz Peñarrocha RM,Amézaga Menéndez R,Burgueño Laguía P,Grupos de Trabajo de la Sociedad Española de Medicina Intensiva CYU,Grupos de Trabajo de la Sociedad Española de Medicina Intensiva CYU,Grupo de Trabajo de Cuidados Intensivos Cardiológicos YRCP,Grupo de Trabajo de Cuidados Intensivos N,Grupo de Trabajo de Donación Trasplantes Y,Grupo de Trabajo de Enfermedades Infecciosas Sepsis Y,Grupo de Trabajo de Evaluación de Tecnologías Metodología de la Investigación Y,Grupo de Trabajo de Insuficiencia Respiratoria A,Grupo de Trabajo de Metabolismo Nutrición Y,Grupo de Trabajo de Neurointensivismo Trauma Y,Grupo de Trabajo de Planificación OYG,Grupo de Trabajo de Sedación AYD,Grupo de Trabajo de S,Grupo de Trabajo de T,Grupo de Trabajo de Transfusiones Hemoderivados Y,Grupo de Trabajo de Transporte C,Junta D. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19). Med. Intensiv. 2020. 44. (6):p. 371-388. IF:2,491. (Q3).

Estella Á,Saralegui I,Rubio Sanchiz O,Hernández Tejedor A,López Camps V,Martín MC,Cabré Pericas L,Masnou Burralló N,Recuerda Nuñez M,Monzón JL. Update and recommendations in decision making referred to limitation of advanced life support treatment. Med. Intensiv. 2020. 44. (2):p. 101-112. IF:2,491. (Q3).

Caballeria L,Augustin S,Broquetas T,Morillas RM,Vergara M,Virolés S,Hernández MR,Serra I,Goday A,Vila L,Siso Almirall A,Solans R,Fernández Real JM,Carrión JA,Graupera I,Ginès P. Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care. Med Clin (Barc). 2019. 153. (4):p. 169-177. IF:1,635. (Q3).

Díaz de Cerio Canduela P,Arán González I,Barberá Durban R,Sistiaga Suárez A,Tobed Secall M,Parente Arias PL,en representación del Grupo de trabajo de Rehabilitación del LARINGECTOMIZADO. Rehabilitation of the laryngectomised patient. Recommendations of the Spanish Society of Otolaryngology and Head and Neck Surgery. Acta Otorrinolaringol. Esp. 2019. 70. (3):p. 169-174.

Transfer to clinical practice

IDIBGI has the exploitation rights of the Spanish translation of the Leicester Cough Questionnaire, from the Pneumology Service, as a result of an initiative led by Dr. Montserrat Vendrell.

If you are interested in using the Spanish version of the questionnaire, please contact us.

Spin-offs

GoodGut is a biotechnology start-up that emerged from the IDIBGI-led Digestive diseases and microbiota research group under Dr. Xavier Aldeguer, and the Universitat de Girona (UdG). GoodGut is engaged in the research and development of non-invasive systems that support the diagnosis and treatment of digestive diseases based on intestinal microbiota as a determining factor.

MetaboStem was a biotechnology company that emerged from the Institut Català d’Oncologia (ICO) and the Metabolism and Cancer Research Group led by Dr. Javier Menéndez. Focused on the development of oncological drugs aimed at Cancer Stem Cells (CSC). It ceased activity in 2016.


Genetic Diagnostic Laboratory

An example of successful impact of technological transference from the IDIBGI materialized in the provision of services by the Cardiovascular genetic Research Group, where the genetic Diagnostic Laboratory (LDG) is located, a joint initiative of the ICS and IDIBGI led by Dr. Brugada, a national and international eminence in the genetic diagnosis of cardiovascular genetic diseases. 

LDG is an example of a translational initiative led by the institute, a reference laboratory dedicated to the diagnosis of cardiovascular genetic diseases, associated with arrhythmias and sudden death, among others. 

The IDIBGI's commitment to encourage LDG activities and services to be extrapolated to the private sector or hospitals in our country while maintaining the necessary scientific and quality standards has resulted in high-value scientific collaborations and a return to the research of the institute.

For more information visit Gencardio Diagnostics

Clinical trials and observational studies

Within the strategy of promoting innovation and transfer to healthcare practice is the activity related to clinical research carried out at healthcare institutions in the area and/or associated with IDIBGI (clinical trials and observational studies), giving patients access to cutting-edge therapies or technologies and establishing links with the pharmaceutical industry, which is often the promoter of this activity.

This research is essential to be able to improve existing therapies and treatment, as well as to find new ones, and to be able to provide the population with better and better quality care.


Clinical trials and observational studies in different therapeutic areas and for different indications are currently being carried out within the framework of clinical research at IDIBGI.

For more information visit Clinical Research or Clinical Trials Unit.

Collaborations

The IDIBGI collaborates with entities, private companies, organizations, and associations through strategic alliances that help promote research initiatives in the field of health, give value to technologies that arise from biomedical research to implement them in the Catalonian health system and the territory. We work to establish strategic alliances with the businesses that result in knowledge of great scientific value and allow us to carry out transfer processes.

Are you a company or institution with an innovative project or challenge and would like to collaborate with the IDIBGI?

Contact

If you are a company and want to collaborate with the IDIBGI on an innovative project,
If you are an investigator at the IDIBGI or an associated institution and you have an innovative idea,
If you are an investigator and want to collaborate with other institutions or companies,
If you are an investigator and need advice regarding intellectual property, creation of companies or technology valuation,

Queralt Farreras

Innovation Technician

About IDIBGI!

menu